×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

 

Modérateur : Pr Jean-Marc Classe

18:00
Quelle est la stratégie chirurgicale ?
Pr Pierre Meeus
18:20
Actualités sur la chimiothérapie de première ligne et les stratégies de maintenance
Pr Isabelle Ray-Coquard
18:40
Comment prendre en charge la patiente âgée ?
Pr Claire Falandry
19:00
Discussion/Débat et réponses aux questions

 

Shooting date : 2021-09-15
Last update : 2021-09-28
1 comment
Join the Discussion
  • zouhour B. En cas de rechute Platine sensible quelle est la place de la chirurgie après disparition ss chimiothérapie de la recidive

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Wednesday, March 12th 2025 from 01pm to 01:45pm (GMT+1)
    Honolulu : Wednesday, March 12th 2025 from 01am to 01:45am (GMT+1)
    San Francisco : Wednesday, March 12th 2025 from 03am to 03:45am (GMT+1)
    New York : Wednesday, March 12th 2025 from 06am to 06:45am (GMT+1)
    Buenos Aires : Wednesday, March 12th 2025 from 08am to 08:45am (GMT+1)
    London / Dublin : Wednesday, March 12th 2025 from 11am to 11:45am (GMT+1)
    Paris / Berlin : Wednesday, March 12th 2025 from 12pm to 12:45pm (GMT+1)
    Istanbul : Wednesday, March 12th 2025 from 01pm to 01:45pm (GMT+1)
    Moscou / Dubaï : Wednesday, March 12th 2025 from 03pm to 03:45pm (GMT+1)
    Bangkok : Wednesday, March 12th 2025 from 06pm to 06:45pm (GMT+1)
    Shanghai : Wednesday, March 12th 2025 from 07pm to 07:45pm (GMT+1)
    Tokyo : Wednesday, March 12th 2025 from 08pm to 08:45pm (GMT+1)
    Sydney : Wednesday, March 12th 2025 from 09pm to 09:45pm (GMT+1)
    Wellington : Wednesday, March 12th 2025 from 11pm to 11:45pm (GMT+1)

    Comment prendre en charge un cancer de l'endomètre avancé ?

    Cancer de l'endomètre avancé dMMR : quelle stratégie en 2025 ? (épisode 1)

    Share
    Saturday, March 22nd 2025 from 09:30am to 12:30pm (GMT+1)
    Honolulu : Friday, March 21st 2025 from 09:30pm to 12:30am (GMT+1)
    San Francisco : Friday, March 21st 2025 from 11:30pm to 02:30am (GMT+1)
    New York : Saturday, March 22nd 2025 from 02:30am to 05:30am (GMT+1)
    Buenos Aires : Saturday, March 22nd 2025 from 04:30am to 07:30am (GMT+1)
    London / Dublin : Saturday, March 22nd 2025 from 07:30am to 10:30am (GMT+1)
    Paris / Berlin : Saturday, March 22nd 2025 from 08:30am to 11:30am (GMT+1)
    Istanbul : Saturday, March 22nd 2025 from 09:30am to 12:30pm (GMT+1)
    Moscou / Dubaï : Saturday, March 22nd 2025 from 11:30am to 02:30pm (GMT+1)
    Bangkok : Saturday, March 22nd 2025 from 02:30pm to 05:30pm (GMT+1)
    Shanghai : Saturday, March 22nd 2025 from 03:30pm to 06:30pm (GMT+1)
    Tokyo : Saturday, March 22nd 2025 from 04:30pm to 07:30pm (GMT+1)
    Sydney : Saturday, March 22nd 2025 from 05:30pm to 08:30pm (GMT+1)
    Wellington : Saturday, March 22nd 2025 from 07:30pm to 10:30pm (GMT+1)

    Transpyrenean Oncogynae Symposium

    Ovarian cancer: from molecular insights to multidisciplinary strategies

    Share
    Monday, April 28th 2025 from 06:30pm to 07:30pm (GMT+2)
    Honolulu : Monday, April 28th 2025 from 06:30am to 07:30am (GMT+2)
    San Francisco : Monday, April 28th 2025 from 09:30am to 10:30am (GMT+2)
    New York : Monday, April 28th 2025 from 12:30pm to 01:30pm (GMT+2)
    Buenos Aires : Monday, April 28th 2025 from 01:30pm to 02:30pm (GMT+2)
    Reykjavik : Monday, April 28th 2025 from 04:30pm to 05:30pm (GMT+2)
    London / Dublin : Monday, April 28th 2025 from 05:30pm to 06:30pm (GMT+2)
    Paris / Berlin : Monday, April 28th 2025 from 06:30pm to 07:30pm (GMT+2)
    Istanbul : Monday, April 28th 2025 from 07:30pm to 08:30pm (GMT+2)
    Moscou / Dubaï : Monday, April 28th 2025 from 08:30pm to 09:30pm (GMT+2)
    Bangkok : Monday, April 28th 2025 from 11:30pm to 12:30am (GMT+2)
    Shanghai : Tuesday, April 29th 2025 from 12:30am to 01:30am (GMT+2)
    Tokyo : Tuesday, April 29th 2025 from 01:30am to 02:30am (GMT+2)
    Sydney : Tuesday, April 29th 2025 from 03:30am to 04:30am (GMT+2)
    Wellington : Tuesday, April 29th 2025 from 05:30am to 06:30am (GMT+2)

    PARPi dans le cancer de l'ovaire en 1L

    Données actuelles et perspectives pour la combinaison avec l’IO

    Share
    Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
    Honolulu : Tuesday, September 5th 2023 from 06:30am to 08am (GMT+2)
    San Francisco : Tuesday, September 5th 2023 from 09:30am to 11am (GMT+2)
    New York : Tuesday, September 5th 2023 from 12:30pm to 02pm (GMT+2)
    Buenos Aires : Tuesday, September 5th 2023 from 01:30pm to 03pm (GMT+2)
    Reykjavik : Tuesday, September 5th 2023 from 04:30pm to 06pm (GMT+2)
    London / Dublin : Tuesday, September 5th 2023 from 05:30pm to 07pm (GMT+2)
    Paris / Berlin : Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
    Istanbul : Tuesday, September 5th 2023 from 07:30pm to 09pm (GMT+2)
    Moscou / Dubaï : Tuesday, September 5th 2023 from 08:30pm to 10pm (GMT+2)
    Bangkok : Tuesday, September 5th 2023 from 11:30pm to 01am (GMT+2)
    Shanghai : Wednesday, September 6th 2023 from 12:30am to 02am (GMT+2)
    Tokyo : Wednesday, September 6th 2023 from 01:30am to 03am (GMT+2)
    Sydney : Wednesday, September 6th 2023 from 03:30am to 05am (GMT+2)
    Wellington : Wednesday, September 6th 2023 from 05:30am to 07am (GMT+2)

    Les nouveaux enjeux de la prise en charge du cancer de l’ovaire en première ligne : L’exemple d...

    Cycle d'enseignement sur le cancer de l'ovaire - Première session

    Share
    Scroll Up